Pharmagen, Inc. (PHRX)

Market Cap	517.00
Revenue (ttm)	4.41M -19.9%
Net Income	-6.43M
EPS	-0.02
Shares Out	517.08M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	0.000001
Previous Close	n/a
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.0001
Beta	0.32
Analysts	Buy
Price Target	0.13 (+12,999,900.0%)
Earnings Date	n/a

About Pharmagen

Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology,...

• Industry: Medical Distribution
• Sector: Healthcare
• Employees: 24
• Stock Exchange: OTCMKTS
• Ticker Symbol: PHRX